who owns the patent for semaglutide Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite What is the patent landscape

The impact of intermittent fasting on gut microbiota: a systematic review of human studies

A researcher might observe a negative outcome and incorrectly attribute it to the peptide itself when the real culprit is a solvent residue, a synthesis byproduct, or incorrect peptide sequencing

Hier kann eine Supplementierung ber ausgewhlte Nahrungsergnzungsmittel sinnvoll sein

For most adults, the first-line approach involves lifestyle modification , including a balanced, calorie-controlled diet and increased physical activity

Cortisol dysregulation driven by gut-derived immune signalling disrupts the normal circadian cortisol rhythm, impairing the deep sleep stages required for cellular repair